Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Gastrointestinal Tolerability of Dimethyl Fumarate in MS (MITIGATE)
NCT02410278Phase 4Completed
- Sponsor
- Biogen
- Start
- Mar 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast, sponsored by Biogen. Started Mar 2015; status: completed.
02
Drugs
montelukast
Beyond the preview
Go deeper on NCT02410278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410278.